Advanced in Delayed Growth

Peter E. Huber

Heidelberg, BW, DE 
Advanced in Delayed Growth
Heidelberg, BW, DE 
OverviewLocationsClinical Research

Overview

Peter Huber practices in Heidelberg, Germany. Mr. Huber is rated as an Advanced expert by MediFind in the treatment of Delayed Growth. His top areas of expertise are Delayed Growth, Adenoid Cystic Carcinoma, Cerebral Hypoxia, Astrocytoma, and Mastectomy.

His clinical research consists of co-authoring 133 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Delayed Growth.

Gender
Male

Locations

Heidelberg, BW 69120, Germany
Other Locations
Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized Phase II Study of Radiation Induced Immune Boost in Operable Non-small Cell Lung Cancer
A Randomized Phase II Study of Radiation Induced Immune Boost in Operable Non-small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: May 23, 2022
Intervention Type: Radiation
Study Phase: Not Applicable
Randomised Phase I/II Trial in Order to Evaluate the Effect of Neoadjuvant Radiation on Tumor Infiltrating T-cells by Neoadjuvant Low-Dose-Radiation Therapy in Primarily Resectable Pancreatic Cancer
Randomised Phase I/II Trial in Order to Evaluate the Effect of Neoadjuvant Radiation on Tumor Infiltrating T-cells by Neoadjuvant Low-Dose-Radiation Therapy in Primarily Resectable Pancreatic Cancer
Enrollment Status: Completed
Publish Date: June 10, 2021
Intervention Type: Radiation
Study Phase: Not Applicable
View 1 Less Clinical Trial

133 Total Publications

Radiotherapy Upregulates the Expression of Membrane-Bound Negative Complement Regulator Proteins on Tumor Cells and Limits Complement-Mediated Tumor Cell Lysis.
Radiotherapy Upregulates the Expression of Membrane-Bound Negative Complement Regulator Proteins on Tumor Cells and Limits Complement-Mediated Tumor Cell Lysis.
Journal: Cancers
Published: June 12, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Huber's expertise for a condition
ConditionClose
      View All 24 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile